Knowledge Intensive Services
4colors Research wins the Airbus-BMW Quantum Computing Challenge awarded at Q2B Silicon Valley
4colors wins the Airbus-BMW Quantum Computing Challenge with a novel, quantum-ready solution for supply chain planning and optimization ...
How to choose the right new hardware for your school or business
Slow isn’t often a word you want to associate with your school or business.When your hardware isn’t performing, you’ll hear it a lot. Complaints about PCs, your internet connection, even your network. Not only is it frustrating, but it’s costing you time, money, and productivity.&n...
Cambridge entrepreneurs address city’s inequality with pioneering £multimillion ‘pay-it- forward’ initiative
Cambridge aims to become world leader in social innovation alongside its academic, life sciences and tech prowess ...
Chris Dunn Wins Top UK Business Adviser Award
Enterprise Nation has named Chris Dunn one of the UK's top small business advisers in recognition of his outstanding contribution to business growth. Chris collected his Award for International Trade at a celebratory event at The Shard in London on Thursday, December 5th, 2024. ...
How future-ready is your school’s or business’s IT?
➡️ How do you feel about the technology you use in your school or business? A recent study found that 90% of managers or business leads felt confident that their IT systems today are “best in class”.❓ But how about tomorrow?💡The same study showed that:➡️ Only 39% of business leader...
Allia celebrates 25 years of driving social impact
Empowering 4,039 ventures, supporting 520 tenants, and arranged and advised on over £4 billion of finance since 1999. ...
Analytics for clinical development strategy: Integrated optimization of an oncology program
Achieving a return on invested capital (ROIC) that exceeds the cost of capital remains a challenge for pharmaceutical R&D. To make progress, there needs to be consistent and rigorous modeling of the clinical and commercial determinants of ROIC. In the second of three articles, CRA’...
CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?
Aduhelm was the first FDA-approved disease-modifying treatment for Alzheimer’s, sparking debate among providers, regulators, and patients. Aduhelm received a controversial accelerated approval from the FDA in June 2021, a decision that balanced the lack of consensuses among the scientif...
Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D
Despite the rapid scientific advances with new targets, modalities, and biomarkers, the return on invested capital (ROIC) in novel therapeutics remains low. The problem stems from the large investment needed, high risks of failure, and long timelines until revenues can be realized. This...
Infertility - A public health concern
The World Health Organization (WHO) estimates that one out of six people globally are impacted by the inability to conceive a child. Over the last decade, countries around the world have seen a decline in total fertility rates, most notably in economically developed countries withi...